Estimating measures of interaction on an additive scale for preventive exposures

European Journal of Epidemiology

Volumn 26, Issue 6, 2011, Pages 433-438

  Knol, Mirjam J ^a   VanderWeele, Tyler J ^b   Groenwold, Rolf H H ^a   Klungel, Olaf H ^c   Rovers, Maroeska M ^a   Grobbee, Diederick E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Interaction; Preventive factors; Relative excess risk due to interaction; Synergy index

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANALYTIC METHOD; ARTICLE; ATTRIBUTABLE PROPORTION; CONTROLLED STUDY; DIABETES MELLITUS; GENE DELETION; GENE INSERTION; GENE INTERACTION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; PREVENTIVE MEDICINE; RELATIVE EXCESS RISK DUE TO INTERACTION; RISK FACTOR; SYNERGY INDEX;

CASE-CONTROL STUDIES; CAUSALITY; DATA INTERPRETATION, STATISTICAL; EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS;

EID: 79959768603     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-011-9554-9     Document Type: Article

References (20)

1. Rothman KJ. Measuring interactions. Epidemiology: an introduction. Oxford: University Press; 2002. p. 168-80.
2. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20:575-9. (Pubitemid 41126030)
3. Greenland S, Rothman KJ. Concepts of interaction. Modern epidemiology. Philadelphia: Lippincott-Raven Publishers; 1998. p. 329-42.
4. Hallqvist J, Ahlbom A, Diderichsen F, Reuterwall C. How to evaluate interaction between causes: a review of practices in cardiovascular epidemiology. J Intern Med. 1996;239:377-82. (Pubitemid 26246418)
5. Rothman KJ. The estimation of synergy or antagonism. Am J Epidemiol. 1976;103:506-11.
6. Vanderweele TJ, Robins JM. The identification of synergism in the sufficient-component-cause framework. Epidemiology. 2007;18:329-39. (Pubitemid 46624942)
7. Rothman KJ. Interactions between causes. Mod Epidemiol. 1986;311-326.
8. Assmann SF, Hosmer DW, Lemeshow S, Mundt KA. Confidence intervals for measures of interaction. Epidemiology. 1996;7:286-90. (Pubitemid 26120376)
9. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992;3:452-6.
10. Richardson DB, Kaufman JS. Estimation of the relative excess risk due to interaction and associated confidence bounds. Am J Epidemiol. 2009;169:756-60.
11. Knol MJ, Tweel IV, Grobbee DE, Numans ME, Geerlings MI. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol. 2007.
12. Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarod K, Holmen J. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis. 2006;47:396-405. (Pubitemid 43255172)
13. Marenholz I, Kerscher T, Bauerfeind A, et al. An interaction between filaggrin mutations and early food sensitization improves the prediction of childhood asthma. J Allergy Clin Immunol. 2009;123:911-6.
14. Yang X, So WY, Ma RC, et al. Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry. Diabetes Care. 2009;32:1826-32.
15. Yang X, Ma RC, So WY, et al. White blood cell count and reninangiotensin system inhibitors for the risk of cancer in type 2 diabetes. Diabetes Res Clin Pract. 2010;87:117-25.
16. de Mutsert R, Jager KJ, Zoccali C, Dekker FW. The effect of joint exposures: examining the presence of interaction. Kidney Int. 2009;75:677-81.
17. Bozkurt O, Verschuren WM, van Wieren-de Wijer BM, et al. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. J Hum Hypertens. 2008;22:774-80.
18. Zou GY. On the estimation of additive interaction by use of the four-by-two table and beyond. Am J Epidemiol. 2008;168: 212-24. (Pubitemid 351951593)
19. Vanderweele TJ, Knol MJ. Remarks on antagonism. Am J Epidemiol. (accepted for publication).
20. Greenland S, Lash TL, Rothman KJ. Concepts of interaction. Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 71-83.